Agents increasing cyclic GMP amplify 5-HT 4-elicited positive inotropic response in failing rat cardiac ventricle

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 384, Issue 6, 2011, Pages 543-553

  Afzal, Faraz ^a,b   Qvigstad, Eirik ^a,b   Aronsen, Jan Magnus ^a,b   Moltzau, Lise Román ^a,b   Sjaastad, Ivar ^a,b,c   Skomedal, Tor ^a,b   Osnes, Jan Bjørn ^a,b   Levy, Finn Olav ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

5 HT 4 receptors; Compartmentation; Cyclic nucleotides; Heart failure; Natriuretic peptides; Phosphodiesterases

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ATRIAL NATRIURETIC FACTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CILOSTAMIDE; CYCLIC GMP; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE III; SEROTONIN 4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; INOTROPISM; MALE; NONHUMAN; RAT;

ANIMALS; CYCLIC GMP; DISEASE MODELS, ANIMAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GUANYLATE CYCLASE; HEART FAILURE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, C-TYPE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, SEROTONIN, 5-HT4;

EID: 83555165893     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0670-6     Document Type: Article

References (40)

1. 4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles Br J Pharmacol 155 1005 1014 18846035 10.1038/bjp.2008.339 1:CAS:528:DC%2BD1cXhsVWhu7bE
2. 2-adrenoceptor- mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle Br J Pharmacol 162 54 71 21133887 10.1111/j.1476-5381.2010.00890.x 1:CAS:528:DC%2BC3MXksFI%3D
3. JK Bendall T Damy P Ratajczak X Loyer V Monceau I Marty P Milliez E Robidel F Marotte JL Samuel C Heymes 2004 Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat Circulation 110 2368 2375 15466641 10.1161/01.CIR.0000145160.04084.AC 1:CAS:528:DC%2BD2cXosVSlsL4%3D (Pubitemid 39407341)
4. 4 receptor antagonist in heart failure Br J Pharmacol 150 143 152 17160012 10.1038/sj.bjp.0706966 1:CAS:528: DC%2BD2sXotFeruw%3D%3D (Pubitemid 46160604)
5. 4 mRNA in heart failure Naunyn-Schmied Arch Pharmacol 370 157 166 10.1007/s00210-004-0963-0 1:CAS:528:DC%2BD2cXns1eqtLs%3D (Pubitemid 39361851)
6. 4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle J Mol Cell Cardiol 43 767 779 17936780 10.1016/j.yjmcc.2007.08.019 1:CAS:528:DC%2BD2sXhtlyrtbfP (Pubitemid 350166381)
7. OE Brodde MC Michel 1999 Adrenergic and muscarinic receptors in the human heart Pharmacol Rev 51 651 690 10581327 1:CAS:528:DC%2BD3cXnslChsLs%3D
8. LR Castro I Verde DM Cooper R Fischmeister 2006 Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes Circulation 113 2221 2228 16651469 10.1161/CIRCULATIONAHA.105.599241 1:CAS:528:DC%2BD28XktVWhtLg%3D
9. T Damy P Ratajczak E Robidel JK Bendall P Oliviero J Boczkowski T Ebrahimian F Marotte JL Samuel C Heymes 2003 Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats FASEB J 17 1934 1936 12897062 1:CAS:528:DC%2BD3sXot1Kit7o%3D
10. T Damy P Ratajczak AM Shah E Camors I Marty G Hasenfuss F Marotte JL Samuel C Heymes 2004 Increased neuronal nitric oxide synthase-derived NO production in the failing human heart Lancet 363 1365 1367 15110495 10.1016/S0140-6736(04)16048-0 1:CAS:528:DC%2BD2cXjtl2lsLo%3D (Pubitemid 38529877)
11. E Degerman P Belfrage VC Manganiello 1997 Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) J Biol Chem 272 6823 6826 9102399 10.1074/jbc.272.11.6823 1:CAS:528:DyaK2sXhvFGqsr4%3D (Pubitemid 27166373)
12. S Del Ry C Passino M Maltinti M Emdin D Giannessi 2005 C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity Eur J Heart Fail 7 1145 1148 15922659 10.1016/j.ejheart.2004.12.009 (Pubitemid 41721117)
13. S Del Ry M Maltinti M Cabiati M Emdin D Giannessi MA Morales 2008 C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure Peptides 29 79 82 18063200 10.1016/j.peptides.2007.10.022 (Pubitemid 50008072)
14. DM Dickey DR Flora PM Bryan X Xu Y Chen LR Potter 2007 Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, not NPR-A, is the predominant natriuretic peptide receptor in the failing heart Endocrinology 148 3518 3522 17412809 10.1210/en.2007-0081 1:CAS:528:DC%2BD2sXntVOnsLc%3D (Pubitemid 46997008)
15. R Fischmeister LR Castro A bi-Gerges F Rochais J Jurevicius J Leroy G Vandecasteele 2006 Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases Circ Res 99 816 828 17038651 10.1161/01.RES.0000246118.98832.04 1:CAS:528:DC%2BD28XhtVKjtL%2FP (Pubitemid 44556380)
16. A Galindo-Tovar ML Vargas AJ Kaumann 2009 Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium Naunyn-Schmied Arch Pharmacol 379 379 384 10.1007/s00210-008-0367-7 1:CAS:528:DC%2BD1MXitFKisb4%3D
17. 4 receptors in the isolated human atrium Naunyn-Schmied Arch Pharmacol 379 349 359 10.1007/s00210-008-0371-y 1:CAS:528:DC%2BD1MXitFKisbg%3D
18. PR Kalra JR Clague AP Bolger SD Anker PA Poole-Wilson AD Struthers AJ Coats 2003 Myocardial production of C-type natriuretic peptide in chronic heart failure Circulation 107 571 573 12566368 10.1161/01.CIR.0000047280.15244.EB 1:CAS:528:DC%2BD3sXmsFCrtg%3D%3D (Pubitemid 36176806)
19. AJ Kaumann FO Levy 2006 5-Hydroxytryptamine receptors in the human cardiovascular system Pharmacol Ther 111 674 706 16960982 10.1016/j.pharmthera. 2005.12.004 1:CAS:528:DC%2BD28Xns1Sks70%3D (Pubitemid 44118434)
20. M Kirstein M Rivet-Bastide S Hatem A Benardeau JJ Mercadier R Fischmeister 1995 Nitric oxide regulates the calcium current in isolated human atrial myocytes J Clin Invest 95 794 802 7860763 10.1172/JCI117729 1:CAS:528:DyaK2MXjsV2rsLo%3D
21. 4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure Eur J Heart Fail 11 771 778 19567409 10.1093/eurjhf/hfp087 1:CAS:528:DC%2BD1MXptFCntrg%3D
22. M Kuhn 2003 Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A Circ Res 93 700 709 14563709 10.1161/01.RES.0000094745.28948.4D 1:CAS:528:DC%2BD3sXnvFags7w%3D (Pubitemid 37288664)
23. J Layland JM Li AM Shah 2002 Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes J Physiol 540 457 467 11956336 10.1113/jphysiol.2001.014126 1:CAS:528: DC%2BD38XjsFWrur0%3D (Pubitemid 35190124)
24. MJ Lohse S Engelhardt T Eschenhagen 2003 What is the role of β-adrenergic signaling in heart failure? Circ Res 93 896 906 14615493 10.1161/01.RES.0000102042.83024.CA 1:CAS:528:DC%2BD3sXoslykurk%3D (Pubitemid 37433227)
25. PB Massion O Feron C Dessy JL Balligand 2003 Nitric oxide and cardiac function. Ten years after and continuing Circ Res 93 388 398 12958142 10.1161/01.RES.0000088351.58510.21 1:CAS:528:DC%2BD3sXmslCmt78%3D (Pubitemid 37100003)
26. M Mukoyama K Nakao K Hosoda S Suga Y Saito Y Ogawa G Shirakami M Jougasaki K Obata H Yasue 1991 Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide J Clin Invest 87 1402 1412 1849149 10.1172/JCI115146 1:CAS:528:DyaK3MXitVSntr0%3D
27. J Nagendran SL Archer D Soliman V Gurtu R Moudgil A Haromy C St Aubin L Webster IM Rebeyka DB Ross PE Light JR Dyck ED Michelakis 2007 Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility Circulation 116 238 248 17606845 10.1161/CIRCULATIONAHA.106.655266 1:CAS:528: DC%2BD2sXnsVyjsr0%3D (Pubitemid 47196559)
28. M Pierkes S Gambaryan P Boknik SM Lohmann W Schmitz R Potthast R Holtwick M Kuhn 2002 Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice Cardiovasc Res 53 852 861 11922895 10.1016/S0008-6363(01)00543-0 1:CAS:528:DC%2BD38Xitlaqtbs%3D (Pubitemid 34261023)
29. 4 receptor-mediated inotropic response to serotonin in heart failure Cardiovasc Res 65 869 878 15721867 10.1016/j.cardiores.2004.11. 017 1:CAS:528:DC%2BD2MXhsVOnu7g%3D (Pubitemid 40249731)
30. 1- adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition Cardiovasc Res 85 763 772 19900965 10.1093/cvr/cvp364 1:CAS:528: DC%2BC3cXitVSrtbw%3D
31. s-coupled receptors in adult rat ventricular myocytes Circ Res 98 1081 1088 16556871 10.1161/01.RES.0000218493.09370.8e 1:CAS:528:DC%2BD28Xjs1Kltro%3D
32. AM Shah PA MacCarthy 2000 Paracrine and autocrine effects of nitric oxide on myocardial function Pharmacol Ther 86 49 86 10760546 10.1016/S0163-7258(99) 00072-8 1:CAS:528:DC%2BD3cXit1WmsLs%3D (Pubitemid 30173144)
33. I Sjaastad OM Sejersted A Ilebekk R Bjørnerheim 2000 Echocardiographic criteria for detection of postinfarction congestive heart failure in rats J Appl Physiol 89 1445 1454 11007581 1:STN:280: DC%2BD3M%2FhslOmtA%3D%3D
34. 1- vs. β-adrenoceptor-mediated inotropic response in rats with congestive heart failure Acta Physiol Scand 177 449 458 12648162 10.1046/j.1365-201X.2003.01063.x 1:CAS:528:DC%2BD3sXjtVakt7g%3D (Pubitemid 36411582)
35. A Stangherlin F Gesellchen A Zoccarato A Terrin LA Fields M Berrera NC Surdo MA Craig G Smith G Hamilton M Zaccolo 2011 cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes Circ Res 108 929 939 21330599 10.1161/CIRCRESAHA. 110.230698 1:CAS:528:DC%2BC3MXkslKmtrY%3D
36. J Su PM Scholz HR Weiss 2005 Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes Exp Biol Med 230 242 250 1:CAS:528:DC%2BD2MXjtFequro%3D (Pubitemid 40478248)
37. E Takimoto D Belardi CG Tocchetti S Vahebi G Cormaci EA Ketner AL Moens HC Champion DA Kass 2007 Compartmentalization of cardiac β-adrenergic inotropy modulation by phosphodiesterase type 5 Circulation 115 2159 2167 17420342 10.1161/CIRCULATIONAHA.106.643536 1:CAS:528:DC%2BD2sXktlSnu7g%3D (Pubitemid 46659068)
38. 2+ current in cardiac myocytes J Mol Cell Cardiol 47 304 314 19345227 10.1016/j.yjmcc.2009.03. 021 1:CAS:528:DC%2BD1MXnsl2it7g%3D
39. JF Wen X Cui JY Jin SM Kim SZ Kim SH Kim HS Lee KW Cho 2004 High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria Circ Res 94 936 943 14988225 10.1161/01.RES.0000123826.70125.4D 1:CAS:528: DC%2BD2cXivVKqs74%3D (Pubitemid 38490071)
40. M Zaccolo MA Movsesian 2007 cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology Circ Res 100 1569 1578 17556670 10.1161/CIRCRESAHA.106.144501 1:CAS:528:DC%2BD2sXmtVGjtLY%3D (Pubitemid 46897260)